FDA is a ticker tracked in our intelligence system with 5 linked articles.
TechCrunch Mobility blends a high-profile EV critique (Ferrari Luce) with regulatory and funding dynamics in mobility and AI, anchored by hard data points like AV registrations, deal sizes, and regulatory shifts.
US Black-founded startups have raised a record $643M in 2026 year-to-date amid a funding downturn, driven by a few large rounds, while regulatory shifts around peptides (FDA advisory committee in July 2026) could reshape the opportunity set.
TechCrunch dissectes Enhanced Games and the wider peptide/health enhancement trend, highlighting a $1.2B IPO, a $50M venue, and high-prize, high-risk athletic and regulatory dynamics driven by Silicon Valley backing.
TechCrunch coverage spans a Snap alumni fund (Ghost Angels) and several regulatory and macro-trends in AI, fintech, and digital advertising, with notable hard data on fund sizes, valuations, and product economics.
TechCrunch covers a $300 Ninja pizza oven review, a landmark Indian ruling on Googleâs trademark keywords, Enhancedâs peptide business with a $1.2B IPO valuation, Cognitionâs AI coding-agent funding, an AI glossary, and disruptive tech-event promotions.
TechCrunchâs Enhanced Games piece links a high-profile biotech/landscape play (peptides) to a Silicon Valley-backed IPO, regulatory scrutiny (FDA committee on peptides), and a broader trend toward âenhancement,â highlighting market size, investment dynamics, and regulatory risk.
Subscribe for real-time ticker updates and unlimited access to our intelligence platform.